Computational Life
Computational Life is dedicated to transforming healthcare outcomes through advanced computational modeling. Specializing in cardiogenic shock management, regulatory support, and R&D advising, the company develops mathematical models that provide innovative solutions at the intersection of clinical care, regulatory strategy, and research development. Their approach combines expertise with cutting-edge technology to address complex healthcare challenges, aiming to improve patient outcomes, streamline regulatory processes, and accelerate medical research.
Industries
Nr. of Employees
small (1-50)
Computational Life
USA 251 Little Falls Drive, Wilmington, New Castle County Delaware 19808-1674
Products
Computational physiological modeling platform
A modular analytical platform that builds physiologically based digital representations of individuals to simulate treatment and disease dynamics for clinical, R&D, and regulatory use cases.
Computational physiological modeling platform
A modular analytical platform that builds physiologically based digital representations of individuals to simulate treatment and disease dynamics for clinical, R&D, and regulatory use cases.
Services
Model‑based predictive support to simulate treatment options and patient hemodynamic responses in cardiogenic shock.
Preparation of in‑silico evidence packages and reports aligned with regulatory guidelines to assist notified body submissions for medical devices and drugs.
Consulting services from project inception through in‑silico evidence generation, including integration with existing models and bespoke model development.
Model‑based predictive support to simulate treatment options and patient hemodynamic responses in cardiogenic shock.
Preparation of in‑silico evidence packages and reports aligned with regulatory guidelines to assist notified body submissions for medical devices and drugs.
Consulting services from project inception through in‑silico evidence generation, including integration with existing models and bespoke model development.
Expertise Areas
- Clinical decision support
- Cardiovascular hemodynamics modeling
- In‑silico clinical trial design
- Model validation and verification
Key Technologies
- Multiscale physiological modeling
- Digital twin of patient physiology
- In‑silico clinical trials
- Uncertainty quantification (UQ)
News & Updates
A scientific paper published in ASAIO Journal on the validation of a multiscale computational model for cardiogenic shock.
A research paper published in Bioimpacts on the function of arteries and veins during simulated cardiac arrest.
Presentations at ASAIO and ESAIO Congresses on the characterization of a multiscale model for cardiogenic shock.
Distributed medical intervention testing on a digitally simulated patient. PCT phase
A patent related to distributed medical intervention testing on a digital patient.
A scientific paper published in ASAIO Journal on the validation of a multiscale computational model for cardiogenic shock.
A research paper published in Bioimpacts on the function of arteries and veins during simulated cardiac arrest.
Presentations at ASAIO and ESAIO Congresses on the characterization of a multiscale model for cardiogenic shock.
Distributed medical intervention testing on a digitally simulated patient. PCT phase
A patent related to distributed medical intervention testing on a digital patient.